{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:03:02Z","timestamp":1788314582235,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"crossref","award":["RP\u2013PG\u20130109\u201310061"],"award-info":[{"award-number":["RP\u2013PG\u20130109\u201310061"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"crossref","award":["RP\u2013PG\u20130109\u201310061"],"award-info":[{"award-number":["RP\u2013PG\u20130109\u201310061"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AstraZeneca"},{"DOI":"10.13039\/501100018952","name":"NIHR Birmingham BRC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018952","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100019719","name":"Chiesi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019719","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Boehringer Ingelheim"},{"name":"Glaxosmithkline"},{"name":"Novartis"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17270-0","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:43:58Z","timestamp":1758807838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The independent and combined effects of smoking and chronic obstructive pulmonary disease on body mass index trajectories"],"prefix":"10.1038","volume":"15","author":[{"given":"Spencer J.","family":"Keene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna H. M.","family":"Driessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Sitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peymane","family":"Adab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits M. E.","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"17270_CR1","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1164\/ajrccm\/139.6.1435","volume":"139","author":"DO Wilson","year":"1989","unstructured":"Wilson, D. O., Rogers, R. M., Wright, E. C. & Anthonisen, N. R. Body weight in chronic obstructive pulmonary disease: the National institutes of health intermittent positive-pressure breathing trial. Am. Rev. Respir Dis. 139, 1435\u20131438 (1989).","journal-title":"Am. Rev. Respir Dis."},{"key":"17270_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/23120541.00051-2015","volume":"2","author":"B Eriksson","year":"2016","unstructured":"Eriksson, B. et al. Only severe COPD is associated with being underweight: results from a population survey. ERJ Open. Res. 2, 1\u201311 (2016).","journal-title":"ERJ Open. Res."},{"key":"17270_CR3","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa021322","volume":"350","author":"B Celli","year":"2004","unstructured":"Celli, B. et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl. J. Med. 350, 1005\u20131012 (2004).","journal-title":"N Engl. J. Med."},{"key":"17270_CR4","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1164\/ajrccm.157.6.9705017","volume":"157","author":"AMWJ Schols","year":"1998","unstructured":"Schols, A. M. W. J., Slangen, J., Volovics, L. & Wouters, E. F. M. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am. J. Respir Crit. Care Med. 157, 1791\u20131797 (1998).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"5","key":"17270_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.5588\/ijtld.18.0456","volume":"23","author":"J-W Jung","year":"2019","unstructured":"Jung, J.-W. et al. Poor nutritional intake is a dominant factor for weight loss in chronic obstructive pulmonary disease. Int J. Tuberc Lung Dis 23(5), 631\u2013637 (2019).","journal-title":"Int J. Tuberc Lung Dis"},{"key":"17270_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1164\/ajrccm\/140.2.385","volume":"140","author":"M Donahoe","year":"1989","unstructured":"Donahoe, M., Rogers, R. M., Wilson, D. O. & Pennock, B. E. Oxygen consumption of the respiratory muscles in normal and in malnourished patients with chronic obstructive pulmonary disease. Am. Rev. Respir Dis. 140, 385\u2013391 (1989).","journal-title":"Am. Rev. Respir Dis."},{"key":"17270_CR7","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1016\/j.rmed.2006.03.008","volume":"100","author":"G Sergi","year":"2006","unstructured":"Sergi, G. et al. Body composition and resting energy expenditure in elderly male patients with chronic obstructive pulmonary disease. Respir Med. 100, 1918\u20131924 (2006).","journal-title":"Respir Med."},{"key":"17270_CR8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/ajcn\/87.4.801","volume":"87","author":"A Chiolero","year":"2008","unstructured":"Chiolero, A., Faeh, D., Paccaud, F. & Cornuz, J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am. J. Clin. Nutr. 87, 801\u2013809 (2008).","journal-title":"Am. J. Clin. Nutr."},{"key":"17270_CR9","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/thoraxjnl-2011-200010","volume":"66","author":"B Van Den Borst","year":"2011","unstructured":"Van Den Borst, B. et al. Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking? Thorax 66, 961\u2013969 (2011).","journal-title":"Thorax"},{"key":"17270_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1335","author":"JD Lewis","year":"2007","unstructured":"Lewis, J. D., Schninnar, R., Bilker, W. B., Wang, X. & Strom, B. L. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. https:\/\/doi.org\/10.1002\/pds.1335 (2007).","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"17270_CR11","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/ijo.2015.116","volume":"39","author":"CD Madigan","year":"2015","unstructured":"Madigan, C. D., Daley, A. J., Kabir, E., Aveyard, P. & Brown, W. Cluster analysis of behavioural weight management strategies and associations with weight change in young women: A longitudinal analysis. Int. J. Obes. 39, 1601\u20131606 (2015).","journal-title":"Int. J. Obes."},{"issue":"1","key":"17270_CR12","doi-asserted-by":"publisher","first-page":"e003667","DOI":"10.1136\/bmjopen-2013-003667","volume":"4","author":"A Peeters","year":"2014","unstructured":"Peeters, A., Magliano, D. J., Backholer, K., Zimmet, P. & Shaw, J. E. Changes in the rates of weight and waist circumference gain in Australian adults over time: A longitudinal cohort study. BMJ Open 4(1), e003667 (2014).","journal-title":"BMJ Open"},{"key":"17270_CR13","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1056\/NEJMoa1014296","volume":"364","author":"D Mozaffarian","year":"2011","unstructured":"Mozaffarian, D., Hao, T., Rimm, E. B., Willett, W. C. & Hu, F. B. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl. J. Med. 364, 2392\u20132404 (2011).","journal-title":"N Engl. J. Med."},{"key":"17270_CR14","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/sj.ijo.0801035","volume":"23","author":"BL Heitmann","year":"1999","unstructured":"Heitmann, B. L. & Garby, L. Patterns of long-term weight changes in overweight developing Danish men and women aged between 30 and 60 years. Int. J. Obes. 23, 1074\u20131078 (1999).","journal-title":"Int. J. Obes."},{"key":"17270_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjdrc-2019-000972","volume":"8","author":"J Lv","year":"2020","unstructured":"Lv, J. et al. Trajectories of early to mid-life adulthood BMI and incident diabetes: the China health and nutrition survey. BMJ Open. Diabetes Res. Care. 8, 1\u20138 (2020).","journal-title":"BMJ Open. Diabetes Res. Care"},{"key":"17270_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-017-4081-6","volume":"17","author":"AL Feldman","year":"2017","unstructured":"Feldman, A. L. et al. Impact of weight maintenance and loss on diabetes risk and burden: a population-based study in 33,184 participants. BMC Public. Health. 17, 1\u201310 (2017).","journal-title":"BMC Public. Health"},{"key":"17270_CR17","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-16401\/v1","author":"M Divo","year":"2020","unstructured":"Divo, M. et al. Somatotypes trajectories during adulthood and its association with chronic obstructive pulmonary disease (COPD) phenotypes. ERJ Open. Res. https:\/\/doi.org\/10.21203\/rs.3.rs-16401\/v1 (2020).","journal-title":"ERJ Open. Res."},{"key":"17270_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40608-016-0120-6","volume":"3","author":"NA Aars","year":"2016","unstructured":"Aars, N. A. & Jacobsen, B. K. Longitudinal changes in desired body weight compared to changes in body weight: evidence of adaptation to weight gain? BMC Obes. 3, 1\u201310 (2016).","journal-title":"BMC Obes."},{"key":"17270_CR19","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1183\/09031936.93.06050729","volume":"6","author":"MFGJ Muers","year":"1993","unstructured":"Muers, M. F. G. J. Weight loss in chronic obstructive pulmonary disease. ERJ 6, 729\u2013734 (1993).","journal-title":"ERJ"},{"key":"17270_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1515\/jtim-2015-0021","volume":"3","author":"G Rawal","year":"2016","unstructured":"Rawal, G. & Yadav, S. Nutrition in chronic obstructive pulmonary disease: A review. J. Transl Intern. Med. 3, 151\u2013154 (2016).","journal-title":"J. Transl Intern. Med."},{"key":"17270_CR21","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1183\/09031936.00070914","volume":"44","author":"AM Schols","year":"2014","unstructured":"Schols, A. M. et al. Nutritional assessment and therapy in COPD: A European respiratory society statement. Eur. Respir J. 44, 1504\u20131520 (2014).","journal-title":"Eur. Respir J."},{"key":"17270_CR22","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1164\/ajrccm.150.5.7952575","volume":"150","author":"M Di Francia","year":"1994","unstructured":"Di Francia, M., Barbier, D., Mege, J. L. & Orehek, J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am. J. Respir Crit. Care Med. 150, 1453\u20131455 (1994).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"17270_CR23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1164\/ajrccm.153.2.8564110","volume":"153","author":"I De Godoy","year":"1996","unstructured":"De Godoy, I., Donahoe, M., Calhoun, W. J., Mancino, J. & Rogers, R. M. Elevated TNF-\u03b1 production by peripheral blood monocytes of weight-losing COPD patients. Am. J. Respir Crit. Care Med. 153, 633\u2013637 (1996).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"17270_CR24","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.1164\/rccm.201402-0373ST","volume":"189","author":"F Maltais","year":"2014","unstructured":"Maltais, F. et al. An official American thoracic society\/european respiratory society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am. J. Respir Crit. Care Med. 189, E15\u2013E62 (2014).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"17270_CR25","first-page":"289","volume":"2","author":"RCI W\u00fcst","year":"2007","unstructured":"W\u00fcst, R. C. I. & Degens, H. Factors contributing to muscle wasting and dysfunction in COPD patients. Int. J. COPD. 2, 289\u2013300 (2007).","journal-title":"Int. J. COPD"},{"key":"17270_CR26","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/ajcn\/43.4.486","volume":"43","author":"BA Stamford","year":"1986","unstructured":"Stamford, B. A., Matter, S., Fell, R. D. & Papanek, P. Effects of smoking cessation on weight gain, metabolic rate, caloric consumption, and blood lipids. Am. J. Clin. Nutr. 43, 486\u2013494 (1986).","journal-title":"Am. J. Clin. Nutr."},{"key":"17270_CR27","first-page":"259","volume":"6","author":"J Wu","year":"2011","unstructured":"Wu, J. & Sin, D. D. Improved patient outcome with smoking cessation: when is it too late? Int. J. COPD. 6, 259\u2013267 (2011).","journal-title":"Int. J. COPD"},{"key":"17270_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2021.7044","volume":"4","author":"BW Sahle","year":"2021","unstructured":"Sahle, B. W., Chen, W., Rawal, L. B. & Renzaho, A. M. N. Weight gain after smoking cessation and risk of major chronic diseases and mortality. JAMA Netw. Open. 4, 1\u201313 (2021).","journal-title":"JAMA Netw. Open."},{"key":"17270_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000353211","volume":"63","author":"E Rutten","year":"2013","unstructured":"Rutten, E. et al. Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence Patient-Related outcomes?? Ann. Nutr. Metab. 63, 239\u2013247 (2013).","journal-title":"Ann. Nutr. Metab."},{"key":"17270_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0164290","volume":"11","author":"LMDO Caram","year":"2016","unstructured":"Caram, L. M. D. O. et al. Smoking and early COPD as independent predictors of body composition, exercise capacity, and health status. PLoS One. 11, 1\u201312 (2016).","journal-title":"PLoS One"},{"issue":"1","key":"17270_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1465-9921-8-25","volume":"8","author":"NS Hopkinson","year":"2007","unstructured":"Hopkinson, N. S. et al. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 8(1), 25 (2007).","journal-title":"Respir Res"},{"key":"17270_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/1479972315626012","volume":"13","author":"LEGW Vanfleteren","year":"2016","unstructured":"Vanfleteren, L. E. G. W. et al. Body mass index and chronic airflow limitation in a worldwide population-based study. Chron. Respir Dis. 13, 90\u2013101 (2016).","journal-title":"Chron. Respir Dis."},{"key":"17270_CR33","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1183\/13993003.00692-2015","volume":"46","author":"EPA Rutten","year":"2015","unstructured":"Rutten, E. P. A. et al. Continuous fat-free mass decline in COPD: fact or fiction? Eur. Respir J. 46, 1496\u20131498 (2015).","journal-title":"Eur. Respir J."},{"key":"17270_CR34","first-page":"1","volume":"354","author":"M Roland","year":"2016","unstructured":"Roland, M. & Guthrie, B. Quality and outcomes framework: what have we learnt? BMJ 354, 1\u20134 (2016).","journal-title":"BMJ"},{"key":"17270_CR35","first-page":"5","volume":"7","author":"JH Kim","year":"2012","unstructured":"Kim, J. H. et al. Cigarette smoking increases abdominal and visceral obesity but not overall fatness: an observational study. PLoS One. 7, 5\u20139 (2012).","journal-title":"PLoS One"},{"key":"17270_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/jcsm.12062","volume":"7","author":"KJC Sanders","year":"2016","unstructured":"Sanders, K. J. C., Kneppers, A. E. M., van de Bool, C., Langen, R. C. J. & Schols, A. M. W. J. Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective. J. Cachexia Sarcopenia Muscle. 7, 5\u201322 (2016).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"17270_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-019-1073-3","volume":"20","author":"MLN McDonald","year":"2019","unstructured":"McDonald, M. L. N. et al. It\u2019s more than low BMI: prevalence of cachexia and associated mortality in COPD. Respir Res. 20, 1\u20139 (2019).","journal-title":"Respir Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17270-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17270-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17270-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:44:01Z","timestamp":1758807841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17270-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17270"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17270-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AS reports grants from NIHR Birmingham BRC during the conduct of the study and grants from Astra Zeneca outside the submitted work; REJ reports grants from NIHR, outside the submitted work and membership of Boehringer Ingelheim primary care advisory board; PA reports grants from NIHR Programme Grant, during the conduct of the study; and is Chair of the NIHR PHR Funding committee; FMEF has received grants and personal fees from AstraZeneca, Chiesi, Boehringer Ingelheim, Glaxosmithkline, Novartis and MSD outside the submitted work. All other authors declare no conflicts of interest in relation to the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Patients and\/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient and public involvement"}},{"value":"The Health Improvement Network (THIN) is a longitudinal, clinical primary care database that contains anonymised and validated data on diagnoses, symptoms, hospital referrals, discharge summaries, lifestyle, mortality, prescribing, and clinical and laboratory tests captured by general practitioners using Vision medical software (Vision, London, UK). The NHS South East Multi-centre Research Ethics Committee (MREC) approved the use of THIN data for research purposes in 2003, subject to independent scientific review, which we obtained (approval 16THIN039) on May 23, 2016. The need for individual informed consent was waived by the NHS MREC because the study used de-identified data collected during routine primary care. This waiver is consistent with national regulations governing the secondary use of anonymized health data in the UK. The study adhered to the principles of the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"32883"}}